Christopher M. Starr

Insider Reports History

Entity
Individual
Location
C/O Monopar Therapeutics Inc, 1000 Skokie Blvd., Suite 350, Wilmette, IL
Signature
/s/ Kim R. Tsuchimoto, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christopher M. Starr:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Monopar Therapeutics Director Common Stock 49.4K $16.8K $0.34 Dec 31, 2023 Indirect
Monopar Therapeutics Director Common Stock 25.9K $8.8K $0.34 Dec 31, 2023 Direct
Monopar Therapeutics Director Restricted Stock Units 0 $0.34 Dec 31, 2023 Direct

Insider Reports Filed by Christopher M. Starr

Symbol Company Period Transactions Value $ Form Type Date Filed Role
MNPR Monopar Therapeutics Dec 31, 2023 2 $0 4 Jan 3, 2024 Director
MNPR Monopar Therapeutics Sep 30, 2023 2 $0 4 Oct 3, 2023 Director
MNPR Monopar Therapeutics Jun 30, 2023 2 $0 4 Jul 3, 2023 Director
MNPR Monopar Therapeutics Mar 31, 2023 2 $0 4 Apr 4, 2023 Director
MNPR Monopar Therapeutics Feb 1, 2023 2 $0 4 Feb 3, 2023 Director
MNPR Monopar Therapeutics Dec 31, 2022 2 $0 4 Jan 3, 2023 Director
MNPR Monopar Therapeutics Sep 30, 2022 2 $0 4 Oct 3, 2022 Director
MNPR Monopar Therapeutics Jun 30, 2022 2 $0 4 Jul 1, 2022 Director
MNPR Monopar Therapeutics Mar 31, 2022 2 $0 4 Apr 1, 2022 Director
MNPR Monopar Therapeutics Feb 2, 2022 2 $0 4 Feb 4, 2022 Director
MNPR Monopar Therapeutics Dec 31, 2021 2 $0 4 Jan 4, 2022 Director
MNPR Monopar Therapeutics Sep 30, 2021 2 $0 4 Oct 1, 2021 Director
MNPR Monopar Therapeutics Jun 30, 2021 2 $0 4 Jul 2, 2021 Director